Viewing StudyNCT06554626



Ignite Creation Date: 2024-10-25 @ 7:53 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06554626
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-06

Brief Title: Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
Sponsor: None
Organization: None

Conditions & Keywords Data

Conditions:
Keywords: